Intervention

PSMA PET/CT scan

ClinicalTrials.gov intervention label

Clinical trials4

Recruiting2

Common conditions9

Lead sponsors shown4

Clinical trials

4 shown

PSMA PET for Surveillance After Focal TherapyNCT07115914 · 2025-11-19

PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)NCT07089550 · 2025-04-02

Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate CancerNCT06919159 · 2021-07-01

PSMA PET/CT for Assessment of Recurrent Prostate CancerNCT02899312 · 2017-03-16

ACTIVE_NOT_RECRUITING

Common conditions

Prostate Cancer (Diagnosis)2 Positron Emission Tomography (PET)1 Prostate Cancer1 Prostate Cancer (Adenocarcinoma)1 Prostate Cancer Metastatic1 Prostate Cancer Metastatic Disease1 Prostate-specific Membrane Antigen1 Prostatic Neoplasms1 PSMA Positive Tumors or Tumor Tissues1

Leading sponsors

British Columbia Cancer Agency1 IRCCS Azienda Ospedaliero-Universitaria di Bologna1 Jiequn Yu1 University of Chicago1

Trial status mix

RECRUITING2

ACTIVE_NOT_RECRUITING1

COMPLETED1

Phase mix

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.